CIA
AGIO icon

CSat Investment Advisory’s Agios Pharmaceuticals AGIO Stock Holding History

CSat Investment Advisory’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-297
Closed -$10K – 531
2020
Q3 		$10K Buy
297
+39
+15% +$1.71K ﹤0.01% 1034
2020
Q2 		$14K Sell
258
-19
-7% -$880 ﹤0.01% 940
2020
Q1 		$10K Buy
277
+43
+18% +$1.99K ﹤0.01% 900
2019
Q4 		$11K Buy
234
+28
+14% +$1.06K ﹤0.01% 953
2019
Q3 		$7K Buy
206
+28
+16% +$1.16K ﹤0.01% 998
2019
Q2 		$9K Buy
+178
New +$9.51K ﹤0.01% 898

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CSat Investment Advisory's AGIO Position: Q4 2020 in Review

CSat Investment Advisory sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 297 shares — an estimated $10K sold.

CSat Investment Advisory first reported a position in AGIO in Q2 2019 and held it in 6 quarters. The position peaked at $14K in Q2 2020. 201 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • CSat Investment Advisory reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 297 Agios Pharmaceuticals shares in Q4 2020, an estimated $10K.
  • CSat Investment Advisory first reported a position in Agios Pharmaceuticals in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's Agios Pharmaceuticals position peaked at $14K in Q2 2020.
  • 201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.